GSA CAPITAL PARTNERS LLP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$231
+108.1%
81,688
+262.5%
0.02%
+109.1%
Q1 2023$111
-100.0%
22,534
-81.3%
0.01%
-93.3%
Q2 2022$1,100,000
+619.0%
120,533
+859.4%
0.16%
+685.7%
Q1 2022$153,000
-51.0%
12,564
-26.3%
0.02%
-50.0%
Q3 2019$312,000
-4.6%
17,048
-56.5%
0.04%
+133.3%
Q3 2016$327,000
-6.0%
39,200
-30.0%
0.02%
-18.2%
Q1 2016$348,000
-77.3%
56,019
-38.5%
0.02%
-70.7%
Q4 2015$1,535,000
+52.7%
91,073
+29.5%
0.08%
+53.1%
Q3 2015$1,005,000
+848.1%
70,319
+563.4%
0.05%
+600.0%
Q4 2014$106,000
-36.1%
10,600
-46.5%
0.01%
-22.2%
Q3 2014$166,00019,8000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders